Last $40.63 USD
Change Today -0.37 / -0.90%
Volume 186.7K
XLRN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

acceleron pharma inc (XLRN) Snapshot

Open
$40.82
Previous Close
$41.00
Day High
$41.30
Day Low
$39.91
52 Week High
03/6/14 - $53.93
52 Week Low
09/9/14 - $23.61
Market Cap
1.3B
Average Volume 10 Days
161.7K
EPS TTM
$-1.61
Shares Outstanding
32.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ACCELERON PHARMA INC (XLRN)

Related News

No related news articles were found.

acceleron pharma inc (XLRN) Related Businessweek News

No Related Businessweek News Found

acceleron pharma inc (XLRN) Details

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It develops sotatercept and ACE-536 that are in Phase II clinical trials to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes, and red blood cell disorders; and dalantercept, which is in Phase II clinical trials to inhibit blood vessel formation in tumors through the vascular endothelial growth factor pathway inhibitors. The company is also developing a protein therapeutic candidate, ACE-083, for a first-in-human clinical trial targeting diseases involving muscle loss. It has collaboration, license, and option agreement with Celgene Corporation. The company, formerly known as Phoenix Pharma, Inc., was founded in 2003 and is headquartered in Cambridge, Massachusetts.

80 Employees
Last Reported Date: 03/17/14
Founded in 2003

acceleron pharma inc (XLRN) Top Compensated Officers

Founder, Chief Executive Officer, President a...
Total Annual Compensation: $400.0K
Chief Medical Officer and Senior Vice Preside...
Total Annual Compensation: $380.7K
Senior Vice President and General Counsel
Total Annual Compensation: $319.3K
Compensation as of Fiscal Year 2013.

acceleron pharma inc (XLRN) Key Developments

Acceleron Pharma, Inc. Presents at SunTrust Robinson Humphrey Biotechnology and Pharmaceutical One-on-One Orphan Drug Day, Feb-23-2015

Acceleron Pharma, Inc. Presents at SunTrust Robinson Humphrey Biotechnology and Pharmaceutical One-on-One Orphan Drug Day, Feb-23-2015 . Venue: JW Marriott Essex House, 160 Central Park South, b/w 6th & 7th Avenue, New York, New York, United States.

Acceleron Pharma, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 01:50 PM

Acceleron Pharma, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 01:50 PM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: John L. Knopf, Founder, Chief Executive Officer, President and Director.

Acceleron Pharma, Inc. Presents at RBC Capital Markets Healthcare Conference 2015, Feb-24-2015 04:35 PM

Acceleron Pharma, Inc. Presents at RBC Capital Markets Healthcare Conference 2015, Feb-24-2015 04:35 PM. Venue: The New York Palace Hotel, New York, New York, United States. Speakers: John L. Knopf, Founder, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XLRN:US $40.63 USD -0.37

XLRN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for XLRN.
View Industry Companies
 

Industry Analysis

XLRN

Industry Average

Valuation XLRN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 57.7x
Price/Book 7.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 50.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACCELERON PHARMA INC, please visit www.acceleronpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.